# Interferon ß-1b Treatment by Cyclical Administration

> **NCT00270816** · PHASE2,PHASE3 · COMPLETED · sponsor: **S. Andrea Hospital** · enrollment: 60 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon-ß-1b
- **DRUG:** Interferon ß-1b

## Key facts

- **NCT ID:** NCT00270816
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-08
- **Final completion:** 2011-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270816, "Interferon ß-1b Treatment by Cyclical Administration". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00270816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*